★ Market Insights⦁ Theme TrackerBiotechnology & HealthcareⓁ Gene Editing CRISPR Cures Blood Disorders and Scrambles Coronavirus Treatments utilizing Clustered Regularly Interspace Short Palindromic Repeats (CRISPR), continue to rack up clinical success. The latest research on blood…McAlinden Research PartnersJune 16, 2020
★ Market Insights⦁ Theme TrackerBiotechnology & HealthcareⓁ Gene Editing CRISPR Defies COVID-19 as Gene Editing Stocks Continue Their Climb Though many sectors have been whacked by the Coronavirus-related hurdles in 2020, research and development of the gene editing technology…McAlinden Research PartnersMay 13, 2020
★ Market Insights⦁ Theme TrackerBiotechnology & Healthcare Chinese Healthcare Exports Continue Their COVID Surge China is ramping up its manufacturing of medical goods, including masks, PPE, and ventilators, as it seeks to ship them…McAlinden Research PartnersApril 28, 2020
★ Market InsightsBiotechnology & Healthcare COVID Vaccine Rush Should Raise Concerns All sizes of pharmaceutical firms from giants like Johnson & Johnson to young guns like Moderna, yet to bring their…McAlinden Research PartnersApril 1, 2020
★ Market InsightsBiotechnology & Healthcare Coronavirus Propels Telemedicine into the Spotlight Coronavirus could be the game changer that propels telemedicine into the mainstream. Virtual clinical services have been around since the…McAlinden Research PartnersMarch 16, 2020
★ Market Insights⦁ Theme TrackerBiotechnology & Healthcare Pharma’s First Coronavirus Shortage Comes Sooner than Expected The FDA and a number of major pharmaceutical firms have warned of drug shortages resulting from chemical plant shut downs…McAlinden Research PartnersMarch 3, 2020
★ Market InsightsBiotechnology & HealthcareEnergy & EnvironmentTechnology Here are the Market Winners & Losers of Coronavirus The coronavirus outbreak aka 2019-nCoV is having an outsize impact on some industries and their share prices. Airline, energy, and…McAlinden Research PartnersFebruary 3, 2020
★ Market Insights⦁ Theme TrackerBiotechnology & Healthcare MRP Adds Long China Health Care as a Theme in the Wake of 2019-nCoV Outbreak A virus called 2019-nCoV that emerged last month in Central China is spreading so fast that it risks becoming a…McAlinden Research PartnersJanuary 23, 2020
★ Market InsightsBiotechnology & HealthcareⓁ Gene Editing Gene Editing Skyrockets into November on New CRISPR Breakthroughs New research on CRISPR techniques that could provide treatments and improved diagnostics for several major viruses and other medical conditions…McAlinden Research PartnersNovember 13, 2019
★ Market Insights⦁ Theme TrackerBiotechnology & HealthcareⓁ Gene Editing Gene-Editing Revenues Beat Wall Street Bets While Novel Methods Promise Thousands more CRISPR Treatments New developments in CRISPR gene editing technology have opened the door to potential cures for 89% of known disease-causing genetic…McAlinden Research PartnersOctober 29, 2019